Siemens Healthineers Türkiye
Laboratuvar Diagnostiği
Answering the call to address the Coronavirus pandemic

Answering the call to address the COVID-19 pandemicBehind every laboratorian is the support of 53,000 Healthineers

The urgency and complexity of the current COVID-19 situation continues to grow, and laboratorians play an essential role. Testing for SARS-CoV-2 is not the only need in managing COVID-19 patients. Fast, accurate screening and monitoring for the variety of health issues that may arise as part of COVID-19 disease management are also needed.

The essential role of laboratory diagnostics in SARS-CoV-2 infection

We are committed to helping laboratorians navigate this new world, in order to help you provide the best care to patients in this challenging time. Laboratory testing plays an extended role in managing COVID-19 patients.

At Siemens Healthineers, we support our partners throughout the healthcare system by helping them deliver high-value care to patients.

GALLERY: Infographics to learn about COVID-19 Testing

SARS-CoV-2 Total Assay¹

Secure your community with science and scale

Download the infographic (pdf)

Diagnostic testing for COVID-19

As a truly emergent human pathogen, a specific test for presence of the virus did not exist with the onset of cases, necessitating rapid development. Most current testing for infection relies on detection of the viral RNA using a reverse-transcription polymerase chain reaction (rtPCR).

FTD SARS-CoV-2 Assay**

For the identification of Coronavirus SARS-CoV-2, Now CE-IVD Registered

In addition, serology testing from a blood sample can identify antibody to the virus.^1,2 These tests will likely prove extremely valuable for surveillance and could potentially provide assessment for immunity, as well as aiding identification of acute infection.

Antibody Testing Is Critical in Overcoming the COVID-19 Pandemic—Now and in the Future

Recognizing the critical need for accurate diagnostic testing to manage COVID-19, we have developed a total antibody test to detect both IgM and IgG antibodies to SARS-CoV-2 in blood.*

Highly accurate antibody tests help inform clinical and public health decisions, and can be used as an adjunct to PCR tests to aid in clinical assessment.^3,4

SARS-CoV-2 IgG Assay***

Rapid and accurate antibody testing on a large scale is key to address the challenges of the COVID-19 pandemic. Over time, SARS-CoV-2 IgG antibodies remain the primary antibodies present. ^‡

SARS-CoV-2 Total Assay***

Secure your community with science and scale

SARS-CoV-2 Antigen Assay

Lab-based antigen testing for rapid virus detection: Time to first result in as little as 26 minutes*

*Atellica IM SARS-CoV-2 Ag assay

As availability and supplies for molecular testing for COVID-19 increase, testing turn-around times should improve, but remain contingent on sample collection, proper preanalytical handling (RNA is highly degradable), time to test result, and access to testing (point-of-care vs. lab-based).

When used as part of a comprehensive mitigation strategy, the CLINITEST® Rapid COVID-19 Antigen Test can serve as an effective tool to help communities identify infected individuals and isolate outbreaks.^†

CLINITEST® Rapid COVID-19 Antigen Test

Scalable COVID-19 antigen testing in minutes for any setting

Learn how Siemens Healthineers is working hard to provide the best possible support to healthcare providers at each stage of COVID-19 patient care:diagnosis, prognosis, therapy, and follow-up.

Covid-19 employee story Frisch Group Shot

Read news and stories about diagnostics and COVID-19 (İngilizce)

News

Stories

PEPconnect Resources

To support you during the ongoing global crisis, PEPconnect is now offering online education on COVID-19. Get resources on coronavirus information, health and wellness, infection prevention and control, and the patient experience.

Go to PEPconnect

Additional educational resources

COVID-19 Laboratory Testing Guide

Testing is critical to differentiate COVID-19 from other respiratory disease such as influenza or RSV (respiratory syncytial virus). Widespread testing will both inform a COVID-19 diagnosis and aid a greater understanding of disease prevalence, especially in infections that are asymptomatic.

Download the COVID-19 Laboratory Testing Guide (pdf)

Consolidated Assay Menu for Covid-19 Patients (pdf) 0.78 MB

COVID-19: Scientific publications

This collection of information about the COVID-19 pandemic from trusted sources offers useful information to clinicians and healthcare providers fighting the virus worldwide. The content linked on this page includes clinical studies, the latest data, webinars, and clinicians’ first-hand experiences.

Go to COVID-19: Scientific publications

Siemens Healthineers coagulation abnormalities testing guide

Download eBook: Coagulation abnormalities in COVID-19 patients

As part of our commitment to labs and clinicians in the fight against the pandemic, we aim to keep you informed on current coagulation testing and monitoring recommendations in COVID-19 patients. Read our eBook for an overview on:

Thrombosis risk factors
ISTH-recommended coagulation testing algorithm
Leading recommendations for anticoagulation treatment
Relevant parameters for patient monitoring

Download the eBook

Services & Support

Education & Training

The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.

Ehterinton, D. https://techcrunch.com/2020/03/27/the-fda-just-okayed-multiple-15-minute-blood-tests-to-screen-for-coronavirus-but-there-are-caveats/ (Accessed March 28, 2020)

Morris, A. https://www.azcentral.com/story/news/local/arizona-health/2020/03/28/university-arizona-working-tests-detect-covid-19-antibodies/5083093002/ (Accessed March 28, 2020)

https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-covid-19-antibody-testing-primer.pdf Accessed July, 27, 2020

https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html Accessed July 27, 2020

*Under development. Not available for sale. Future availability cannot be guaranteed.

**CE-IVD labeled for diagnostic use in the EU. This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21. U.S.C. § 360bbb- 3(b)(1), unless the authorization is terminated or revoked sooner.

***This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary by country and is subject to regulatory requirements.

^† POC Rapid Tests are distributed by Siemens Healthineers. Not available for sale in the U.S. Product availability varies by country.

^‡ Not available for sale in the U.S. Product availability varies from country to country and is subject to varying regulatory requirements.